Seminars in Nuclear Medicine
Volume 38, Issue 1 , Pages 82-102, January 2008

International Scientific Committee of Radionuclides in Nephrourology (ISCORN) Consensus on Renal Transit Time Measurements

  • Emmanuel Durand, MD, PhD

      Affiliations

    • Univ Paris-Sud, Department of Biophysics and Nuclear Medicine, Le Kremlin-Bicêtre, France.
    • Corresponding Author InformationAddress reprint requests to Emmanuel Durand, MD, PhD, Service de Biophysique et Médecine Nucléaire–CHU Bicêtre, 78 rue du Général Leclerc, F94275 Le Kremlin-Bicêtre, France.
  • ,
  • M. Donald Blaufox, MD, PhD

      Affiliations

    • Department of Nuclear Medicine, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, NY.
  • ,
  • Keith E. Britton, MD, MSc, FRCR, FRCP

      Affiliations

    • Department of Nuclear Medicine, St Bartholomew’s Hospital and Barts and the London, Queen Mary School of Medicine and Dentistry, University of London, London, United Kingdom.
  • ,
  • Ove Carlsen, MSc, PhD

      Affiliations

    • Department of Nuclear Medicine, Vejle Hospital, Vejle, Denmark.
  • ,
  • Philip Cosgriff, MSc

      Affiliations

    • Medical Physics Department, Pilgrim Hospital, Boston, Lincolnshire, United Kingdom.
  • ,
  • Eugene Fine, MD, MS

      Affiliations

    • Department of Nuclear Medicine, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, NY.
  • ,
  • John Fleming, PhD

      Affiliations

    • Southampton University Hospitals NHS Trust, Southhampton, United Kingdom.
  • ,
  • Cyril Nimmon, BSc

      Affiliations

    • Department of Nuclear Medicine, St Bartholomew’s Hospital, London, United Kingdom (retired).
  • ,
  • Amy Piepsz, MD, PhD

      Affiliations

    • Centre Hospitalo-Universitaire St Pierre, Brussels, Belgium.
  • ,
  • Alain Prigent, MD, PhD

      Affiliations

    • Univ Paris-Sud, Department of Biophysics and Nuclear Medicine, Le Kremlin-Bicêtre, France.
  • ,
  • Martin Šamal, MD, PhD

      Affiliations

    • Department of Nuclear Medicine, Charles University Prague and the General Teaching Hospital, Prague, Czech Republic.

This report is the conclusion of the international consensus committee on renal transit time (subcommittee of the International Scientific Committee of Radionuclides in Nephrourology) and provides recommendations on measurement, normal values, and analysis of clinical utility. Transit time is the time that a tracer remains within the kidney or within a part of the kidney (eg, parenchymal transit time). It can be obtained from a dynamic renogram and a vascular input acquired in standardized conditions by a deconvolution process. Alternatively to transit time measurement, simpler indices were proposed, such as time of maximum, normalized residual activity or renal output efficiency. Transit time has been mainly used in urinary obstruction, renal artery stenosis, or renovascular hypertension and renal transplant. Despite a large amount of published data on obstruction, only the value of normal transit is established. The value of delayed transit remains controversial, probably due to lack of a gold standard for obstruction. Transit time measurements are useful to diagnose renovascular hypertension, as are some of the simpler indices. The committee recommends further collaborative trials.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Note: Throughout the text, the symbol “±” stands for standard deviation.

 Conflicts of interest: K.E.B. was a consultant to Nuclear Diagnostics Ltd (Hermes work stations) from October 2004 to October 2005; he is no longer involved with this company.

 The publication of this paper was made possible by a grant from ISCORN (A. Prigent) and contributions from A.T. Taylor and M.D. Blaufox.

PII: S0001-2998(07)00115-8

doi:10.1053/j.semnuclmed.2007.09.009

Seminars in Nuclear Medicine
Volume 38, Issue 1 , Pages 82-102, January 2008